Covance

Dallas, Texas 75247-4989

0 studies enrolling now · 22 studies all time

What they study most

Abnormalities, Cardiovascular, Bioavailability of ASP015K, Celiac Disease, Dyslipidemia, Healthy, Healthy Subjects, Osteoporosis, Postmenopausal, Pharmacokinetics of ASP015K, Pharmacokinetics of Isavuconazole, Pharmacokinetics of Sirolimus

Studies at this site

• A Study of LY3154885 in Healthy Participants — Stopped early
• A Study of LY3074828 in Healthy Participants — Completed
• A Study of Tirzepatide (LY3298176) in Healthy Participants — Completed
• A Study of Two Different Formulations of LY3074828 in Healthy Participants — Completed
• Study of Ixekizumab in Healthy Participants — Stopped early
• A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers — Completed
• A Study of LY3478006 in Healthy Participants — Stopped early
• A Study of LY3556050 in Healthy Participants — Completed
• A Safety Study of LY3372689 in Healthy Participants — Completed
• A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease — Completed
• A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants — Completed
• A Study of Lasmiditan in Healthy Japanese and Caucasian Participants — Completed
• A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants — Completed
• A Study of Different Injectable Formulations of LY3375880 in Healthy Participants — Completed
• A Safety Study of LY3372689 Given By Mouth to Healthy Participants — Completed
• A Study of Galcanezumab in Healthy Participants. — Completed
• A Study of Galcanezumab in Healthy Participants — Completed
• A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women — Stopped early
• A Study of Evacetrapib in Participants With Abnormal Cholesterol — Completed
• A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants — Completed
• A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects — Completed
• A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015K — Completed